New Jersey Assembly Bill A1115

New Jersey 2026-2027 Regular Session

• Introduced: 1/13/26
• Refer: 1/13/26

Caption

Creates certain protections for insurers and insurance producers engaging in business of insurance in connection with cannabis-related businesses.

Impact

If enacted, A1115 will significantly impact how insurance companies and producers operate within the context of cannabis businesses, thereby providing much-needed legal clarity in a sector often hampered by conflicting regulations. It seeks to safeguard insurers from punitive actions by government agencies if they choose to offer insurance products to cannabis enterprises. This reflects a broader trend toward legitimizing the cannabis industry in states where it has been legalized, facilitating the growth of cannabis-related businesses by assuring them access to necessary insurance services.

Summary

Assembly Bill A1115 proposes to create specific protections for insurers and insurance producers who engage in the business of insurance related to cannabis-related businesses in New Jersey. The bill defines a 'cannabis-related business' as any enterprise involved in activities such as cultivating, manufacturing, or selling cannabis products, aligning its stipulations with existing state laws regarding cannabis. Importantly, the bill seeks to ensure that no state or local government agency has the authority to discourage insurers from participating in the insurance markets relevant to these businesses.

Conclusion

In conclusion, A1115 represents a critical step toward facilitating the integration of cannabis-related businesses within the broader economy by ensuring that insurance options are accessible. By constraining the power of state and local governments to intervene negatively in this sector, the bill reflects an evolving recognition of the economic potential of the cannabis industry while navigating the complexities of compliance with both state and federal laws.

Contention

Opposition to A1115 may arise from concerns about the implications of insurance engagement with cannabis businesses, particularly regarding public safety and regulatory compliance. Critics might argue that offering insurance to cannabis businesses could inadvertently lend legitimacy to activities that are still illegal under federal law, leading to complications in enforcement and regulation. Therefore, while A1115 provides protections, it could also raise ethical and legal questions about the insurance industry's role in the growing cannabis market.